Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Nalagenetics obtains CE Mark for its pharmacogenomics software, Nala Clinical Decision Support™ Module- PGx Core 2022-05-31 21:09
Rensselaer Polytechnic Institute and Icahn School of Medicine at Mount Sinai Announce Joint Center for Engineering and Precision Medicine 2022-05-31 21:00
HistoSonics Hits Pivotal Clinical Trial Milestone In #HOPE4LIVER Studies 2022-05-31 21:00
MGI and King Abdullah International Medical Research Center Announce Partnership for Genomic Research 2022-05-31 20:33
ETNA™ DEVICE FROM THE LEADING DIGITAL HEALTH & AI COMPANY INNODEM NEUROSCIENCES RECEIVES FDA "BREAKTHROUGH" DESIGNATION FOR MULTIPLE SCLEROSIS 2022-05-31 18:00
DSM and Firmenich to merge, becoming the leading creation and innovation partner in nutrition, beauty and well-being 2022-05-31 13:00
Winner Medical Announces to Acquire 55% Stake in Zhejiang Longterm Medical for US $108.2 Million 2022-05-31 11:35
Medical training in Vietnam impressively attracts international students. 2022-05-30 20:08
Golden Meditech Stem Cells Responds to Blue Ocean's misleading 13D/A filing 2022-05-30 19:31
Sirnaomics Launches Phase I Clinical Trial of RNAi Therapeutic STP705 in Adults Undergoing Abdominoplasty for Medical Cosmetology Treatment 2022-05-30 16:40
Experts attending P&G Health's Global Webinar Series highlight underdiagnosis concerns as Peripheral Neuropathy becomes more prevalent 2022-05-30 16:12
Northern Health using The Clinician's digital health platform to expand their Victorian Virtual Emergency Department Statewide 2022-05-30 13:18
UAE powerhouse VPS Healthcare launches Burjeel Holdings to scale the next generation of its growth 2022-05-30 11:27
RhoVac's phase IIb study in prostate cancer , BRaVac, failed to meet its primary endpoint 2022-05-30 11:04
United BioPharma Receives TFDA Approval for Phase 2 IND for UB-221 to Treat Chronic Spontaneous Urticaria 2022-05-30 10:59
Illuccix® Reimbursement Milestone and Launch Updates: Pass-Through Status Granted in the U.S. 2022-05-30 08:02
MedAlliance's SELUTION SLR drug-eluting balloon (DEB) receives FDA investigational device exemption (IDE) approval, making it the first limus DEB to be available to US patients 2022-05-30 08:00
Embracing Win-win Cooperation - ASEAN Consul Generals, officials and representatives of chambers of commerce in Guangzhou visited Biosyngen 2022-05-28 09:00
Taiwan's AcadeMab develops groundbreaking therapy for COVID-19 Omicron variant with potent neutralizing efficacy 2022-05-27 11:40
Adagene Announces Publication at ASCO of Interim Monotherapy Dose Escalation Data Showing Compelling Safety Profile of Anti-CTLA-4 SAFEbody® ADG126, with Repeat Dosing Across Dose Levels 2022-05-27 09:30
1 200 201 202 203 204 741